Circulating cell-free DNA in the peripheral blood plasma of patients is an informative biomarker for multiple myeloma relapse

被引：0
|
作者：
Hiroshi Yasui
Masayuki Kobayashi
Kota Sato
Kanya Kondoh
Tadao Ishida
Yuta Kaito
Hideto Tamura
Hiroshi Handa
Yutaka Tsukune
Makoto Sasaki
Norio Komatsu
Norina Tanaka
Junji Tanaka
Masahiro Kizaki
Toyotaka Kawamata
Junya Makiyama
Kazuaki Yokoyama
Seiya Imoto
Arinobu Tojo
Yoichi Imai
机构：
[1] The University of Tokyo,Department of Hematology/Oncology, The Institute of Medical Science
[2] The University of Tokyo,Division of Molecular Therapy, The Institute of Medical Science
[3] Tokyo Metropolitan Bokutoh Hospital,Department of Hematology
[4] Japanese Red Cross Medical Center,Department of Hematology
[5] Nippon Medical School,Department of Hematology
[6] Dokkyo Medical University Saitama Medical Center,Division of Diabetes, Endocrinology and Hematology, Department of Internal Medicine
[7] Gunma University Graduate School of Medicine,Department of Medicine and Clinical Science
[8] Juntendo University School of Medicine,Department of Hematology
[9] Tokyo Women’s Medical University,Department of Hematology
[10] Saitama Medical University,Department of Hematology, Saitama Medical Center
[11] The University of Tokyo,Human Genome Center, The Institute of Medical Science
来源：
International Journal of Clinical Oncology | 2021年 / 26卷
关键词：
Multiple Myeloma; Next generation sequencing; Liquid biopsy; Biomarker; Relapse;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2142 / 2150
页数：8
相关论文
共 50 条
  • [1] Circulating cell-free DNA in the peripheral blood plasma of patients is an informative biomarker for multiple myeloma relapse
    Yasui, Hiroshi
    Kobayashi, Masayuki
    Sato, Kota
    Kondoh, Kanya
    Ishida, Tadao
    Kaito, Yuta
    Tamura, Hideto
    Handa, Hiroshi
    Tsukune, Yutaka
    Sasaki, Makoto
    Komatsu, Norio
    Tanaka, Norina
    Tanaka, Junji
    Kizaki, Masahiro
    Kawamata, Toyotaka
    Makiyama, Junya
    Yokoyama, Kazuaki
    Imoto, Seiya
    Tojo, Arinobu
    Imai, Yoichi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (11) : 2142 - 2150
  • [2] Circulating cell-free DNA in the patient's peripheral blood plasma is a sensitive biomarker for multiple myeloma relapse
    Yasui, Hiroshi
    Kobayashi, Masayuki
    Kondoh, Kanya
    Ishida, Tadao
    Tamura, Hideto
    Handa, Hiroshi
    Sasaki, Makoto
    Tanaka, Norina
    Tanaka, Junji
    Kizaki, Masahiro
    Kawamata, Toyotaka
    Makiyama, Junya
    Yokoyama, Kazuaki
    Imoto, Seiya
    Tojo, Arinobu
    Imai, Yoichi
    CANCER SCIENCE, 2021, 112 : 507 - 507
  • [3] Monitoring multiple myeloma in the peripheral blood based on cell-free DNA and circulating plasma cells
    Mack, Elisabeth K. M.
    Hartmann, Soren
    Ross, Petra
    Wollmer, Ellen
    Mann, Christoph
    Neubauer, Andreas
    Brendel, Cornelia
    Hoffmann, Jorg
    ANNALS OF HEMATOLOGY, 2022, 101 (04) : 811 - 824
  • [4] Monitoring multiple myeloma in the peripheral blood based on cell-free DNA and circulating plasma cells
    Elisabeth K. M. Mack
    Sören Hartmann
    Petra Ross
    Ellen Wollmer
    Christoph Mann
    Andreas Neubauer
    Cornelia Brendel
    Jörg Hoffmann
    Annals of Hematology, 2022, 101 : 811 - 824
  • [5] The level and integrity of plasma circulating cell-free DNA in patients with primary multiple myeloma
    Shen, Qian
    Cen, Haiyan
    Jiang, Jing
    Cong, Zhirong
    Zhou, Ying
    Huang, Xiaoxiao
    Zhu, Li
    Jiang, Qi
    Xue, Chenqi
    TRANSLATIONAL CANCER RESEARCH, 2022, 11 (11) : 4137 - 4147
  • [6] Cell-Free Circulating DNA Integrity Based on Peripheral Blood as a Biomarker for Diagnosis of Cancer: A Systematic Review
    Cheng, Jie
    Tang, Qiuqiong
    Cao, Xue
    Burwinkel, Barbara
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2017, 26 (11) : 1595 - 1602
  • [7] Circulating cell-free DNA in plasma of colorectal cancer patients - A potential biomarker for tumor burden
    Bhangu, Jagdeep Singh
    Taghizadeh, Hossein
    Braunschmid, Tamara
    Bachleitner-Hofmann, Thomas
    Mannhalter, Christine
    SURGICAL ONCOLOGY-OXFORD, 2017, 26 (04): : 395 - 401
  • [8] Identification of multiple informative genomic mutations by deep sequencing of circulating cell-free tumor DNA in plasma of metastatic melanoma patients.
    Hoon, Dave S. B.
    Huang, Sharon
    Sebisanovic, Dragan
    Slew, LaiMun
    Zapanta, Aubrey
    Mortimer, Stefanie
    Talasaz, AmirAli
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [9] Circulating cell-free DNA content as blood based biomarker in endometrial cancer
    Cicchillitti, Lucia
    Corrado, Giacomo
    De Angeli, Martina
    Mancini, Emanuela
    Baiocco, Ermelinda
    Patrizi, Lodovico
    Zampa, Ashanti
    Merola, Roberta
    Martayan, Aline
    Conti, Laura
    Piaggio, Giulia
    Vizza, Enrico
    ONCOTARGET, 2017, 8 (70) : 115230 - 115243
  • [10] Quantifying circulating cell-free DNA as clinical biomarker
    Romain, M.
    Dache, Z. A. A.
    Otandault, A.
    Tanos, R.
    Pastor, B.
    Sanchez, C.
    Azzi, J.
    Tousch, G.
    Azan, S.
    Mollevi, C.
    Thezenas, S.
    Blache, P.
    Thierry, A. R.
    ANNALS OF ONCOLOGY, 2018, 29
12345